Y90 radioembolization involves placing radioactive capsules into the blood vessel feeding your tumor. It’s primarily used for cancer that can’t be treated with surgery or a liver transplant.

The FDA approved Y-90 resin microspheres for the treatment of unresectable hepatocellular carcinoma, according to a press ...

The FDA approved SIR-Spheres Y-90 resin microspheres for unresectable liver cancer, the only radioembolization approved in ...

A study led by clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS) and Singapore General Hospital (SGH) has determined the benefits of using a higher dosage of ...

Liver cancer is treated through surgery as much as possible. A partial hepatectomy is a surgery to remove the cancerous portion of the liver. ... Radioembolization can slow, stop or shrink tumors by ...

Approval was based on results from the DOORwaY90 trial, which demonstrated a 98.5% overall response rate and 100% local tumor control in patients treated with the SIR-Spheres Y-90 resin microspheres ...

Radioembolization therapy uses substances to cut off the blood supply to the tumor. ... Advanced liver cancer has no standard curative treatment.

Primary liver cancer affects more men than women and is usually found in people with chronic liver disease. ... Beads filled with radiation are sometimes used in radioembolization therapy.

The clinical value of radioembolization in the treatment of inoperable liver cancer. US Gastroenterology & Hepatology Review 4 , 32–36 (2009). Google Scholar ...

MARTINSBURG, WV — WVU Medicine Berkeley Medical Center is now offering a new treatment for liver cancer, according to a community announcement. Y-90 radioembolization is a minimally invasive ...

Chennai: In a meaningful step towards transforming liver cancer care in India, Apollo Proton Cancer Centre (APCC), Chennai, ...

Sirtex Medical ("Sirtex"), a leading manufacturer of interventional oncology solutions, today announced that the U.S. Food ...